Skip to main content
. 2010 Jan;13(1):59–65. doi: 10.1089/jpm.2009.0220

Table 5.

Base-Case Cost-Effectiveness Analysis (Additional Scenario)

Strategy Cost Inc. Cost Effect (mos) Eff. (yrs) Inc. Eff. (mos) Inc. Eff. (yrs) Inc. C/E (yrs)
Talc $8170.80   3.3826 0.281      
Pleurx $9288.00 1117.20 3.3219 0.277 −0.06 −0.005 Dominated